Evaluation of MR contrast agents with high relaxivity and reduced interstitial diffusion for contrast material-enhanced MRA and myocardial perfusion studies.
Canet Soulas
Emmanuelle P
EP
Département de Radiologie, Hĵpital Cardiovasculaire et Pneumologique L. Pradel, Lyon, France.
Marchand
Bruno
B
Casali
Cendrine
C
Corot
Claire
C
Douek
Philippe
P
Revel
Didier
D
D000818:Animals; D003287:Contrast Media / Q000737:chemistry / Q000493:pharmacokinetics*; D003326:Coronary Circulation; D006571:Heterocyclic Compounds / Q000737:chemistry / Q000493:pharmacokinetics*; D018810:Magnetic Resonance Angiography; D009206:Myocardium / Q000378:metabolism*; D009942:Organometallic Compounds / Q000737:chemistry / Q000493:pharmacokinetics*; D011817:Rabbits; D013552:Swine
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate